Showing results (221-230 of 281) with videos related to

Sort By:
Pageof 29
Journal of Biological Regulators and Homeostatic Agents|April 1, 1987
Generation and characterization of cytotoxic activity against tumor cell lines in human peripheral blood mononuclear cells stimulated "in vitro" by a glucomannan-protein preparation of Candida albicansC M Ausiello, G C Spagnoli, G Antonelli, et al.
Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
60-kDa heat shock protein of Chlamydia pneumoniae is a target of T-cell immune responseC M Ausiello, R Palazzo, F Spensieri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strainsC Girmenia, P Martino, F De Bernardis, et al.
Cellular Immunology|June 25, 1998
Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicansG Arancia, A Stringaro, P Crateri, et al.
Journal of Medical Microbiology|November 1, 1986
Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractionsC M Ausiello, G C Spagnoli, M Boccanera, et al.
Nature Biotechnology|February 1, 1997
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activityW Magliani, S Conti, F de Bernardis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1996
Human natural yeast killer toxin-like candidacidal antibodiesL Polonelli, F De Bernadis, S Conti, et al.
Journal of Biological Regulators and Homeostatic Agents|November 6, 2001
Macrophages: a crucial reservoir for human immunodeficiency virus in the bodyE Balestra, C F Perno, S Aquaro, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2aE Garaci, M Lopez, G Bonsignore, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil deliveryG Silecchia, E Guarino, P Sinibaldi-Vallebona, et al.
Pageof 29